Is Pirfenidone/Asire Capsules included in medical insurance in 2024?

Pirfenidone/Pirfenidone is an oral drug used to treat idiopathic pulmonary fibrosis (IPF). Idiopathic pulmonary fibrosis is a progressive lung disease characterized by progressive scarring of lung tissue, leading to decreased lung function and difficulty breathing. The mechanism of action of pirfenidone is mainly by inhibiting the activity of fibrosis-related cytokines and growth factors, thereby slowing down the progression of the disease and improving the quality of life of patients.

Clinical studies of pirfenidone have shown that this drug can effectively reduce the rate of decline of lung function and delay the progression of the disease. In some randomized controlled trials, patients taking pirfenidone experienced a significantly slower decline in lung function than those taking placebo, and its use was associated with improved quality of life. This makes pirfenidone widely recognized in the treatment of idiopathic pulmonary fibrosis.

Regarding the marketing status of pirfenidone in China, the drug was approved by the State Food and Drug Administration in 2018 and was marketed for the treatment of idiopathic pulmonary fibrosis. With its launch, it has been gradually accepted by doctors and patients clinically, and has become one of the important choices for the treatment of idiopathic pulmonary fibrosis. According to the latest information, pirfenidone has been included in the medical insurance reimbursement catalog in some areas, improving patient accessibility and reducing the burden of medication. Specific reimbursement policies and scope may vary depending on the medical insurance policies of various provinces and cities. Therefore, patients are advised to consult their local medical insurance department or medical institution to obtain the latest information before using this drug.

In clinical application, the side effects of pirfenidone include gastrointestinal discomfort, rash, fatigue, etc. Doctors will evaluate the patient's specific situation when prescribing to ensure that patients can use the drug safely. In addition, patients need to undergo regular pulmonary function monitoring and liver function tests while using pirfenidone to detect and deal with possible adverse reactions in a timely manner.